<DOC>
	<DOCNO>NCT01834495</DOCNO>
	<brief_summary>The purpose investigator study examine compare primary patency balloon expandable cobalt chromium stent self expandable nitinol stent ( SCUBA versus COMPLETE-SE ) atherosclerotic iliac artery lesion .</brief_summary>
	<brief_title>Efficacy Balloon-Expandable Stent Versus Self-Expandable Stent Atherosclerotic ILIAC Arterial Disease</brief_title>
	<detailed_description>Obstructive atherosclerotic disease distal aorta iliac artery preferentially treat endovascular technique , endovascular-first strategy recommend TransAtlantic Inter-Society Consensus ( TASC ) A-C lesion . Low morbidity mortality well &gt; 90 % technical success rate justify endovascular-first approach . Currently , In attempt improve outcome , stent use increase , number study favor iliac stenting simple PTA . A meta-analysis comparing iliac stenting PTA find stenting high rate technical success associate 39 % reduction risk long-term loss patency . However , randomize control trial comparison primary patency balloon expandable stent self expandable stent do , although trial primary patency compare among balloon expandable stent among self expandable stent . Currently , The choice balloon versus self expandable stent determine mainly operator preference . The main advantage balloon expandable stent higher radial stiffness accurate placement , especially important bifurcation lesion . In external iliac artery , primary stenting strategy use self-expandable stent compare provisional stenting prefer mainly due low risk dissection elastic recoil . Thus , purpose study examine compare primary patency balloon expandable stent self expandable stent ( SCUBA versus COMPLETE SE stent )</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1.Clinical criterion : 1. symptomatic peripheralartery disease moderate severe claudication ( Rutherford 23 ) , chronic critical limb ischemia pain rest ( Rutherford 4 ) , chronic critical limb ischemia ischemic ulcer ( Rutherford 56 ) 2 . Patients sign informed consent 2 . Anatomical criterion : 1 . Target lesion length ≥ 4 cm angiographic estimation , 2 . Stenosis 50 % occlusion ipsilateral iliac artery , 3 . Patent ( ≤50 % stenosis ) ipsilateral femoropopliteal artery concomitantly treatable ipsilateral femoropopliteal lesion ( ≤30 % residual stenosis ) , 4 . At least one patent ( le 50 % stenosed ) tibioperoneal runoff vessel . 1 . Disagree write informed consent 2 . Major bleed history within prior 2 month 3 . Known hypersensitivity contraindication follow medication : heparin , aspirin , clopidogrel contrast agent 4 . Acute limb ischemia 5 . Untreated inflow disease distal aorta ( 50 percent stenosis occlusion ) 6 . Patients major amputation ( `` ankle '' amputation ) do , plan require 7 . Patients life expectancy &lt; 1 year due comorbidity 8 . Age &gt; 85 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Peripheral artery disease</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>stent</keyword>
</DOC>